DOJ 'Not Done' With Generic Drug Price-Fixing

The U.S. Department of Justice is not done investigating price-fixing in the pharmaceutical industry, a high-ranking member of the agency said in a criminal antitrust enforcement speech in Miami on Friday....

Already a subscriber? Click here to view full article